Summary: Axsome Therapeutics In. is set to present multiple studies on AXS-12 and solriamfetol at Sleep Europe 2024, the 27th Congress of the European Sleep Research Society. These presentations include topline results from the phase 3 SYMPHONY trial of AXS-12 for narcolepsy, … [Read more...]